Cargando…

Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients

BACKGROUND: Total HIV-DNA load in peripheral blood cell (PBMCs) reflects the global viral reservoir that seems not to be affected by antiretroviral treatment. However, some studies report-ed a different permeability of different drugs in cellular compartments. OBJECTIVE: To investigate the relation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bon, Isabella, Calza, Leonardo, Musumeci, Giuseppina, Longo, Serena, Bertoldi, Alessia, D’Urbano, Vanessa, Gibellini, Davide, Magistrelli, Eleonora, Viale, Pier Luigi, Re, Maria Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876918/ https://www.ncbi.nlm.nih.gov/pubmed/29210661 http://dx.doi.org/10.2174/1570162X16666171206121026

Ejemplares similares

Comparison of the Aptima HIV‐1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV‐1 v2.0 Test for HIV‐1 viral load quantification in plasma samples from HIV‐1–infected patients
por: Longo, Serena, et al.
Publicado: (2018)

M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures
por: Musumeci, Giuseppina, et al.
Publicado: (2017)

Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures
por: Bon, Isabella, et al.
Publicado: (2013)

Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients
por: Re, Maria Carla, et al.
Publicado: (2001)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
por: Collins, Sean E., et al.
Publicado: (2015)

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy
por: Calza, Leonardo, et al.
Publicado: (2020)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients
por: Gianotti, Nicola, et al.
Publicado: (2017)

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy
por: Prabhakar, B., et al.
Publicado: (2011)

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy
por: Bhagwat, Priya, et al.
Publicado: (2019)

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
por: Palumbo, Philip J., et al.
Publicado: (2017)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV
por: Correa, Analú, et al.
Publicado: (2020)

301. Risk of Virologic Failure with Antiretroviral Switches in HIV/HCV Co-infections
por: Mosquera, Diana M, et al.
Publicado: (2019)

Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States
por: Elbur, Abubaker Ibrahim, et al.
Publicado: (2023)

Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya
por: Kadima, Julie, et al.
Publicado: (2018)

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study
por: Kiweewa, Francis, et al.
Publicado: (2019)

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection
por: van Paassen, Pien M., et al.
Publicado: (2023)

Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia
por: Segeral, Olivier, et al.
Publicado: (2010)

Antiretroviral Genotypic Resistance Mutations in HIV-1 Infected Korean Patients with Virologic Failure
por: Chin, Bum Sik, et al.
Publicado: (2009)

Antiretroviral adherence and virologic suppression in partnered and unpartnered HIV-positive individuals in southern Brazil
por: de Melo, Marineide Gonçalves, et al.
Publicado: (2019)

Pregnancies in perinatally HIV-infected women: antiretroviral treatment strategies, obstetric and virologic outcomes
por: Cecchini, Diego, et al.
Publicado: (2018)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
por: Bunnell, Kristen L., et al.
Publicado: (2018)

Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa
por: Schoffelen, Annelot F., et al.
Publicado: (2013)

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
por: Meriki, Henry D, et al.
Publicado: (2014)

Correction: Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya
por: Kadima, Julie, et al.
Publicado: (2019)

Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults
por: Moh, Desmorys Raoul, et al.
Publicado: (2022)

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
por: Oliveira, Marta Iglis, et al.
Publicado: (2018)

HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia
por: Jiamsakul, Awachana, et al.
Publicado: (2014)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
por: Melku, Mulugeta, et al.
Publicado: (2020)

Association of Hair Concentrations of Antiretrovirals with Virologic Outcomes Among People Living with HIV in Guangxi, China
por: Zhang, Quan, et al.
Publicado: (2021)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
por: Rai, M. Ali, et al.
Publicado: (2022)

1602. Determinants of Early Virologic Failure Among HIV patients on First-line Antiretroviral Therapy
por: Ramos, Diana G, et al.
Publicado: (2023)

HIV Stigma and Depressive Symptoms are Related to Adherence and Virological Response to Antiretroviral Treatment Among Immigrant and Indigenous HIV Infected Patients
por: Sumari-de Boer, I. Marion, et al.
Publicado: (2011)

Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo
por: Konou, Abla A., et al.
Publicado: (2015)

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients
por: Cooper, C, et al.
Publicado: (2015)

Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2021)

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
por: Loutfy, Mona Rafik, et al.
Publicado: (2013)

Longitudinal virological outcomes and factors associated with virological failure in behaviorally HIV-infected young adults on combination antiretroviral treatment in the Netherlands, 2000 to 2015
por: Weijsenfeld, Annouschka M., et al.
Publicado: (2019)

Prevalence of HIV Antiretroviral Drug Resistance and Its Impacts on HIV-1 Virological Failures in Jiangsu, China: A Cross-Sectional Study
por: Zhou, Ying, et al.
Publicado: (2016)

The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy
por: Rosenblum, Michael, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_85fhid9qrclucvg1on9gbmmb32